The effects of pH and ionic strength on topical delivery of a negatively charged porphyrin (TPPS4)

Journal of Pharmaceutical Sciences

Volumn 97, Issue 10, 2008, Pages 4249-4257

  Gelfuso, Guilherme Martins ^a   Figueiredo, Fábio Vasconcelos ^a   Gratieri, Taís ^a   Lopez, Renata Fonseca Vianna ^a  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

Iontophoresis; Photodynamic therapy; Skin penetration; Topical administration; TPPS4

Indexed keywords

SODIUM CHLORIDE; TETRAKIS(4 SULFOPHENYL)PORPHINE;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DRUG STRUCTURE; ELECTROOSMOSIS; FLUORESCENCE MICROSCOPY; IONIC STRENGTH; IONTOPHORESIS; MALE; NONHUMAN; PH; PHOTODYNAMIC THERAPY; QUANTUM YIELD; RAT; SKIN PENETRATION;

EID: 55749101182     PISSN: 00223549     EISSN: 15206017     Source Type: Journal    
DOI: 10.1002/jps.21295     Document Type: Article

References (27)

1. De Rosa FS, Lopez RF, Thomazine JA, Tedesco AC, Lange N, Bentley MX. 2004. In vitro metabolism of 5-ALA esters derivatives in hairless mice skin homogenate and in vivo PpIX accumulation studies. Pharm Res 21:2247-2252.
2. Allison RR, Downie GH, Cuenca R, Hu XH, Childs CJH, Sibata CH. 2004. Photosensitizers in clinical PDT. Photodiagn Photodyn Ther 1:27-42.
3. Szpringer E, Lutnicki K, Marciniak A. 2004. Photodynamic therapy - Mechanism and employment. Ann Univ Mariae Curie Sklodowska 59:498-502.
4. Lopez RF, Lange N, Guy R, Bentley MV. 2004. Photodynamic therapy of skin cancer: Controlled drug delivery of 5-ALA and its esters. Adv Drug Deliv Rev 56:77-94.
5. Winkelman J. 1962. The distribution of tetraphenylporphinesulfonate in the tumor-bearing rat. Cancer Res 22:589-596.
6. Zima T, Jirsa M, Jirsa M, Jr., Jiráscová M, Bradová V, Stádník B. 2004. Effect of chloroquine wash-out period of photosensitizers in the skin and selected organs in rats. Physiol Res 53:103-108.
7. 4 in skin diseases. Cas Lek Cesk 142:439-493.
8. Gonçalves PJ, Boni LDE, Neto NMB, Rodrigues JJ, Zílio SC, Borissevitch IE. 2005. Effect of protonation on the photophysical properties of meso-tetra (sulfonatophenyl)porphyrin. Chem Phys Lett 407:236-241.
9. Kalia YN, Naik A, Garrison J, Guy GH. 2004. Iontophoretic drug delivery. Adv Drug Deliv Rev 56:619-658.
10. Zempsky WT, Sullivan J, Paulson DM, Hoath SB. 2004. Evaluation of a low dose lidocaine iontophoresis system for topical anesthesia in adults and children: A randomized, controlled trial. Clin Ther 26:1110-1119.
11. Lopez RFV, Bentley MVLB, Delgado-Charro MB, Guy GH. 2001. Iontophoretic delivery of 5-aminolevulinic acid (ALA): Effect of pH. Pharm Res 18:311-315.
12. Lopez RFV, Bentley MVLB, Delgado-Charro MB, Salomon D, Van Den Bergh H, Lange N, Guy GH. 2003. Enhanced delivery of 5-aminolevulinic acid esters by iontophoresis in vitro. Photochem Photobiol 77:304-308.
13. Lopez RFV, Bentley MVLB, Delgado-Charro MB, Guy GH. 2003. Optimization of aminolevulinic acid delivery by iontophoresis. J Control Release 88:65-70.
14. Kochhar C, Imanidis G. 2004. In vitro transdermal iontophoretic delivery of leuprolide under constant current application. J Control Release 98:25-35.
15. Merino V, Kalia YN, Guy RH. 2007. Transdermal therapy and diagnosis by iontophoresis. Trends biotechnol 15:288-290.
16. Green PG, Hinz RS, Kim A, Szoka FC, Jr., Guy RH. 1997. Iontophoretic delivery of a series of tripeptides across the skin in vitro. Pharm Res 8:1121-1127.
17. 4 aggregation in aqueous solutions. Spectrochim Acta Part A 63:227-233.
18. Akins DL, Zhu HR, Guo C. 1994. Absorption and raman scattering by aggregated meso-tetrakis( p-sulfonatophenyl)porphine. J Phys Chem 98:3612-3618.
19. Pasternack RF, Gibbs EJ, Collings PJ, De Paula J, Turzo LC, Terracina A. 1998. A nonconventional approach to supramolecular formation dynamics: The kinetics of assembly of DNA-bound porphyrins. J Am Chem Soc 120:5873-5878.
20. Borissevitch LE, Tominaga TT, Imasato H, Tabak M. 1996. Fluorescence and optical absorption study of interaction of two water soluble porphyrins with bovine serum albumin: The role of albumin and porphyrin aggregation. J Lumin 69:65-76.
21. n, n = 1, 2A, 2O, 3, 4). Spectrochim Acta Part A 59:87-101.
22. Borissevitch IE, Gandini SC. 1998. Photophysical studies of excited-state characteristics of mesotetrakis (4-N-methyl-pyridiniumyl) porphyrin bound to DNA. J Photochem Photobiol B 43:112-120.
23. Delgado-Charro MB, Guy RH. 1994. Characterization of convective flow during iontophoresis. Pharm Res 11:929-935.
24. Hoogstraate AJ, Cullander C, Nagelkerke JF, Senel S, Verhoef JC, Junginger HE, Boddé HE. 1994. Diffusion rates and transport pathways of fluorescein isothiocyanate (FITC)-labeled model compounds through buccal epithelium. Pharm Res 11:83-89.
25. Pikal MJ. 2001. The role of electroosmotic flow in transdermal and iontophoresis. Adv Drug Deliv Rev 46:281-305.
26. Guy RH, Kalia YN, Delgado-Charro MB, Merino V, Lopez A, Marro D. 2000. Iontophoresis: Electrorepulsion and electroosmosis. J Control Release 64:129-132.
27. Nugroho AK, Li GL, Danhof M, Bouwstra JA. 2004. Transdermal iontophoresis of rotigotine across human stratum corneum in vitro: Influence of pH and NaCl concentration. Pharm Res 21:844-850.